Oncolytics Biotech Inc. (ONCY) vs Pliant Therapeutics, Inc. (PLRX)
A side-by-side comparison of Oncolytics Biotech Inc. and Pliant Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ONCY
Oncolytics Biotech Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
PLRX
Pliant Therapeutics, Inc.
$1.03HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
Total return — ONCY vs PLRX
growth of $100 · dividends reinvested · last 6yONCY -77.3% (-21.9%/yr)PLRX -95.2% (-39.6%/yr)ONCY compounded faster over this window
ONCY PLRX
ONCY vs PLRX: by the numbers
- •PLRX is the larger company ($63M vs $60M market cap).
Metrics side by side
Valuation
| Metric | ONCY | PLRX |
|---|---|---|
| P/B ratio | N/A | 0.43 |
Profitability
| Metric | ONCY | PLRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -62.81% |
| ROIC | -1235.48% | -56.22% |
Growth (annualized)
| Metric | ONCY | PLRX |
|---|---|---|
| Total return CAGR (5Y) | -21.00% | -43.17% |
Frequently asked
- How have ONCY and PLRX total returns compared?
- Over the past 5 years, ONCY delivered -21.00% and PLRX delivered -43.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.